We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OYST
2376
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-2,846
Closed -$99.6K
PCSB
2377
DELISTED
PCSB Financial Corporation
PCSB
– –
-6,336
Closed -$88.6K
GBT
2378
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-24,047
Closed -$1.23M
BRG
2379
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
– –
-11,894
Closed -$66.3K
HMTV
2380
DELISTED
Hemisphere Media Group, Inc.
HMTV
– –
-8,577
Closed -$73.2K
WMC
2381
DELISTED
Western Asset Mortgage Capital Corporation
WMC
– –
-1,993
Closed -$45.6K
STXB
2382
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
– –
-5,933
Closed -$61.3K
XLRN
2383
DELISTED
Acceleron Pharma
XLRN
– –
-19,395
Closed -$1.74M
KIN
2384
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-11,530
Closed -$46.1K
FCBP
2385
DELISTED
First Choice Bancorp Common Stock
FCBP
– –
-4,966
Closed -$74.5K
AT
2386
DELISTED
Atlantic Power Corporation
AT
– –
-49,998
Closed -$107K
IPHI
2387
DELISTED
INPHI CORPORATION
IPHI
– –
-18,427
Closed -$1.46M
CBMG
2388
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
– –
-6,199
Closed -$98.1K
TNAV
2389
DELISTED
Telenav Inc.
TNAV
– –
-15,561
Closed -$67.2K
ARA
2390
DELISTED
American Renal Associates Holdings, Inc
ARA
– –
-9,580
Closed -$63.3K
LVGO
2391
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-22,252
Closed -$635K
HTZ
2392
DELISTED
Hertz Global Holdings, Inc.
HTZ
– –
-44,849
Closed -$277K
IMMU
2393
DELISTED
Immunomedics Inc
IMMU
– –
-78,858
Closed -$1.06M
BREW
2394
DELISTED
Craft Brew Alliance, Inc.
BREW
– –
-5,777
Closed -$86.1K
CHAP
2395
DELISTED
Chaparral Energy, Inc.
CHAP
– –
-197,422
Closed -$92.8K
IOTS
2396
DELISTED
Adesto Technologies Corp
IOTS
– –
-12,100
Closed -$135K
AXE
2397
DELISTED
Anixter International Inc
AXE
– –
-12,499
Closed -$1.1M
PGNX
2398
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-12,569
Closed -$47.8K
EQM
2399
DELISTED
EQM Midstream Partners, LP
EQM
– –
-90,125
Closed -$1.06M
STML
2400
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-18,471
Closed -$89.4K
93 94 95
96
97

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.